Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Homo sapiens | CEL | ||||||
GSE263241 |
Targeting the IL-5 pathway in severe asthma
|
8 | PERLA ABIGAIL ALVARADO VAZQUEZ | Dec 05, 2024 | ||||
GSE264510 |
Gene expression of two Ewing sarcoma cell lines (A-673, EW-22), transduced with inducible shRNAs against GLRX3
|
10 |
|
Thomas Georg Philipp Grunewald | Dec 03, 2024 | |||
GSE190042 |
Integration between MCL1 gene co-expression module and the Revised International Staging System enables precise prognostication and prediction of response to proteasome inhibitor-based therapy in individual multiple myeloma
|
93 | Yin Wu | Dec 01, 2024 | ||||
GSE197310 |
Time-dependent expression data from human fibrosarcoma human cell line (HT1080) in collagen matrix with protease inhibitors
|
9 | Oscar Maiques | Dec 01, 2024 | ||||
GSE239957 |
Enrichment of CBP80-associated and eIF4E-associated linear RNAs in SMG6 depleted cells
|
12 | Sung Ho Boo | Nov 28, 2024 | ||||
GSE240092 |
Circular RNAs affect mRNA stability
|
28 |
|
Sung Ho Boo | Nov 28, 2024 | |||
GSE189470 |
Noncoding RNAs induce TDP43 pathology in the ALS-iPSC models
|
4 | Yi-Ying Wu | Nov 24, 2024 | ||||
GSE276395 |
Gene expression dysregulation in whole blood of patients with C. difficile infection
|
278 | Maria Tsakiroglou | Nov 24, 2024 | ||||
GSE276561 |
Identifying bone marrow microenvironmental alterations in multiple myeloma and its precursor conditions using whole bone marrow biopsies
|
997 | Yan Cheng | Nov 22, 2024 | ||||
GSE248516 |
Immunosuppressive inflammation driven by LPS/TLR4 signalling in hepatocellular carcinoma with low immune cell infiltration
|
82 | Sylvie JOB | Nov 20, 2024 | ||||
GSE281811 |
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma
|
16 |
|
Janith Seneviratne | Nov 13, 2024 | |||
GSE279598 |
Integrated multi-modal analysis reveals tumor and immune characteristics that distinguish Epstein-Barr virus-positive and -negative B cell post-transplant lymphoproliferative disorders [Affymetrix]
|
7 |
|
Jiaying Toh | Nov 12, 2024 | |||
GSE279991 |
Integrated multi-modal analysis reveals tumor and immune characteristics that distinguish Epstein-Barr virus-positive and -negative B cell post-transplant lymphoproliferative disorders
|
13 | Jiaying Toh | Nov 12, 2024 | ||||
GSE280642 |
Differential KEAP1/NRF2-mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy [array]
|
24 | Nikolas Gunkel | Nov 11, 2024 | ||||
GSE280643 |
Differential KEAP1/NRF2-mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy
|
|
74 |
|
Nikolas Gunkel | Nov 11, 2024 | ||
GSE281068 |
ADAR1 Deficiency Relies upon NOCT to Activate Endothelial Innate Immunity and Apoptosis.
|
9 |
|
Shu-Ting Cho | Nov 11, 2024 | |||
GSE281144 |
Gut Adaptation After Gastric Bypass in Humans Reveals Metabolically Significant Shift in Fuel Metabolism
|
34 |
|
Margaret Stefater-Richards | Nov 09, 2024 | |||
GSE250030 |
Pseudohypoxia Due to PHD2 Deficiency Induces Endothelial Resistance to Apoptosis and Inflammation Independent of HIF2 alpha via AKT Activation and AIP1 Loss
|
20 | Gabriela A Ferreyra | Nov 06, 2024 | ||||
GSE273850 |
Expression data from human trisomy 21 and euploid fibroblasts, iPSCs, and neural progenitor cells
|
51 | Laura L Baxter | Nov 06, 2024 | ||||
GSE112293 |
Characterization of innate immune responses to AS03 adjuvanted H5N1 vaccine compared to non-adjuvanted H5N1 vaccine.
|
898 |
|
Foo Cheung | Nov 05, 2024 |